Research Associate II - Hematologic Malignancies jobs in United States
cer-icon
Apply on Employer Site
company-logo

City of Hope · 11 hours ago

Research Associate II - Hematologic Malignancies

City of Hope is at the forefront of groundbreaking research, changing lives in the fight against cancer and other life-threatening illnesses. The Research Associate II will direct laboratory work and undertake research projects, contributing significantly beyond the RA I level.

AssociationEducationHealth Care
check
Comp. & Benefits

Responsibilities

Perform a variety of routine and non-routine laboratory research experiments. Record and validate results for accuracy and completeness
Troubleshoot procedures if experiment results are unexpected or unsatisfactory. Recommend alternative procedures
Accurately record work performed including results and methodology. Calculate, compile, and analyze data obtained from work performed
Independently evaluate research data and initiate alternative approaches to improve the quality of results by providing input to overall research design. Train lab staff in specialized procedures, equipment, and theoretical concepts behind unique tests
May contribute to the preparation of manuscripts by describing methods and specialized techniques. Keep abreast of new and improved techniques
Ensure that all laboratory activities are carried out in compliance with each procedure(s) by utilizing safety procedures and guidelines in handling, storage and disposal of bio-hazardous, infectious and toxic material

Qualification

Laboratory researchData analysisResearch designTraining staffSafety procedures

Required

Bachelor's degree
Two years related research/ laboratory experience with a Bachelor's degree or one year related research/ laboratory experience with a Master's degree

Preferred

Master's degree preferred

Company

City of Hope

company-logo
City of Hope is a cancer research and treatment non-profit organization specializing in diabetes and other life-threatening illnesses.

Funding

Current Stage
Late Stage
Total Funding
$10.3M
Key Investors
California Institute for Regenerative Medicine
2024-05-20Grant· $5.4M
2022-02-22Grant· $4.9M

Leadership Team

leader-logo
Samuel Lau
Vice President Marketing & Digital Communications
linkedin
leader-logo
Alan H. Bryce
Chief Clinical Officer
linkedin
Company data provided by crunchbase